Internal Medicine, Critical Care Medicine · Cleveland, OH
NPI
1932373826
Since 2008
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9500 Euclid Ave, A9-125
Cleveland, OH, 44195
Phone (216) 444-7943
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
333 services
Medicare patients, 2024
153
Average age 70
Drug cost, 2024
$6.4M
968 prescriptions
Company payments, 2025
$89K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neal F Chaisson was code 99291 (critical care e&m), 99 times for 48 patients. In total Neal F Chaisson billed 333 services in 29 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 99 | 48 | $161.57 | $16K |
| 99215 Office E&M - Established | Facility | 27 | 20 | $82.43 | $2,225 |
| 99214 Office E&M - Established | Facility | 24 | 21 | $70.45 | $1,691 |
| 36556 Venous Catheter Insertion | Facility | 23 | 20 | $63.86 | $1,469 |
| 76937 Ultrasound - Nonspecific | Facility | 23 | 18 | $10.51 | $242 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 17 | $89.42 | $1,878 |
| 36620 Vascular | Facility | 20 | 18 | $33.52 | $670 |
| 94621 Pulmonary Function Testing | Facility | 16 | 16 | $41.27 | $660 |
By year: 2022 $32K for 303 services; 2023 $38K for 356 services; 2024 $30K for 333 services.
Medicare prescription drug claims, 2024
In 2024, the drug Neal F Chaisson prescribed most often to Medicare patients was Ambrisentan, with 133 prescriptions and refills. In total Neal F Chaisson wrote 968 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ambrisentan Generic | 133 | 133 | 13 | $386K |
| Sildenafil Citrate Generic | 109 | 151 | 16 | $61K |
| Opsumit Macitentan | 101 | 101 | 12 | $1.3M |
| Tadalafil Generic | 66 | 74 | Under 11 | $49K |
| Uptravi Selexipag | 64 | 64 | Under 11 | $1.4M |
| Adempas Riociguat | 59 | 59 | Under 11 | $806K |
| Orenitram Er Treprostinil Diolamine | 50 | 50 | Under 11 | $350K |
| Tyvaso Dpi Treprostinil | 48 | 48 | Under 11 | $1.1M |
| Adcirca Tadalafil | 45 | 45 | Under 11 | $158K |
| Letairis Ambrisentan | 30 | 30 | Under 11 | $373K |
| Azithromycin Generic | 29 | 29 | Under 11 | $698 |
| Furosemide Generic | 29 | 41 | Under 11 | $109 |
| Winrevair Sotatercept-Csrk | 28 | 28 | Under 11 | $434K |
| Spironolactone Generic | 17 | 34 | Under 11 | $128 |
Brand drugs: 505 claims; generic drugs: 463 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neal F Chaisson $89K ($89K in general payments such as food, travel and fees) from 4 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $72K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.